Can You Stop TRT? What Happens to Testosterone After Ending Therapy?

Sooner or later, almost every man on testosterone replacement therapy asks himself this question: what would happen if I just stopped? Sometimes it's out of curiosity, sometimes because the therapy has become logistically burdensome, and sometimes because the money for another prescription and follow-up labs has run out. Whatever the reason, the answer requires understanding more than just the fact that testosterone will "drop" — because how it drops, how fast, and whether the body handles it on its own depends on several specific variables worth knowing before stopping becomes a fact rather than a self-run experiment.

This article doesn't address whether TRT is a lifelong or reversible therapy in the general sense — we settle that in detail in a separate piece on treatment duration and types of hypogonadism. Here we're interested in something more practical: exactly what happens in the body in the days, weeks, and months after the last dose, what a realistic timeline for the return of one's own hormone production looks like, why symptoms can temporarily be worse than before starting therapy, and how to stop TRT in a way that doesn't put your health at risk.

To understand what happens after stopping, it helps to briefly recall what therapy has been doing to the body from day one. Exogenous testosterone circulating in the blood is read by the hypothalamus and pituitary exactly the same way as testosterone produced by the testes themselves — the brain "sees" a high hormone level and, via negative feedback, curtails GnRH secretion, and with it LH and FSH. Without LH, the Leydig cells in the testes stop being stimulated to produce their own testosterone, and without proper stimulation the testes shrink over time. We describe this mechanism, along with its consequences for fertility, in detail in a separate article on TRT and fertility — here it's enough to remember one thing: the longer this suppression lasts, the longer reversing it can take.

The first thing worth understanding: testosterone in the blood doesn't vanish immediately after the last dose. How long it stays near therapeutic levels depends mainly on the delivery form and the half-life of the specific ester. Gel or cream testosterone is absorbed and eliminated fastest — blood levels start noticeably dropping within 1–2 days of the last application. Short-acting ester injections, like propionate, lose their effect within a few days. Enanthate and cypionate testosterone, popular in Poland, have a half-life of roughly 4–8 days, so the hormone stays at a detectable, though declining, level for several weeks after the last injection. The longest-acting is testosterone undecanoate given in a long-acting formulation (injections every 10–14 weeks) — here hormone concentration tapers off gradually over many weeks, even months, before dropping below the therapeutic threshold.

That distinction has practical significance: a man stopping TRT delivered as long-acting injections may not notice any difference for a while — not because the hormonal axis has already resumed working, but because residual testosterone from the last dose is still circulating in the body. This false sense of security during that period is one of the reasons patients mistakenly assume they'll "handle" stopping well, before the real test even arrives — the moment when the hormone level from the injection actually runs out and the body's own axis has to take over production.

This is where the most surprising mechanism kicks in: once residual testosterone from therapy runs out, hormone levels in the blood don't smoothly return to pre-treatment values — they first drop below them. The reason is simple and follows directly from the axis suppression described above: LH and FSH, suppressed for months or years by therapy, don't spring back to full activity the moment the external testosterone disappears. The hypothalamus and pituitary first have to "relearn" how to secrete GnRH and LH at the right rhythm, and the testes — deprived of stimulation for a long time — first have to regain the ability to respond effectively to that signal once it finally reappears.

In practice this produces a period, sometimes called the "hormonal trough," during which blood testosterone levels can be lower than they were before the man ever started therapy — because at that point both exogenous testosterone (since therapy has ended) and endogenous testosterone (since the own axis hasn't yet ramped up) are simultaneously lacking. This period is usually the toughest symptomatically and most often lasts from a few to several dozen weeks, though for some men — especially after longer therapy at high doses — it can be markedly longer.

There's no single number that answers the question "how long will this take" — and anyone who states one without qualification is oversimplifying reality. How fast and how completely one's own testosterone production returns depends on several independent factors that layer on top of each other.

In the literature describing recovery of hypothalamic-pituitary-gonadal axis function after stopping exogenous testosterone — mainly from research on male hormonal contraception, where testosterone was deliberately used to suppress the axis and its recovery then observed — the typical picture looks like this: some men regain normal axis function within about six months, the large majority within a year, and for the rest the process stretches to two years or longer. The probability of full recovery and the pace of that process in these studies depended significantly on the man's age — the older the patient, the slower and less certain the recovery.

It's worth stressing that the data above come mainly from healthy men without prior hypogonadism, whose axis functioned normally before the study — a somewhat more favorable scenario than the typical TRT patient, who often already had some degree of axis impairment before starting therapy. In patients with secondary or functional hypogonadism, especially if the underlying cause wasn't fixed, recovery tends to be slower and less certain than in these studies — so these numbers are best treated as an indicative, not a guaranteed, scenario.

One of the most underappreciated aspects of stopping TRT is just how symptomatically unpleasant the transitional period can be. Fatigue, reduced libido, worsening mood, irritability, sleep trouble, a drop in motivation to train, and sometimes worsened urinary symptoms or sexual wellbeing — this is the typical set of symptoms accompanying testosterone dropping below the physiological threshold. Because, as described above, hormone levels during this period can fall below pre-treatment values, many patients describe this stage as subjectively worse than the state that prompted them to start treatment in the first place.

This study concerns interruption for organizational reasons rather than a deliberate, planned discontinuation aimed at fixing the underlying cause of hypogonadism — but the mechanism it observes is exactly the same: since TRT doesn't treat the cause, only replaces the missing hormone, stopping it without addressing the root cause of the original deficiency in practice reverses the gains made, rather than locking them in.

If, after talking with your prescribing doctor, stopping TRT is a real, justified option — for example because the original cause of functional hypogonadism has been successfully fixed — there are several elements that separate a safe, medically supervised discontinuation from a risky, sudden stop on your own.

For some patients, especially after longer therapy or with a markedly suppressed axis, the doctor may propose additional pharmacological support aimed at speeding up and improving the odds of the return of one's own production — this is a real, clinically used strategy, not an experimental curiosity. Human chorionic gonadotropin (hCG) is most commonly used for this, directly stimulating Leydig cells to produce testosterone regardless of whether the pituitary has already resumed its own LH secretion, along with selective estrogen receptor modulators (SERMs) such as clomiphene or enclomiphene, which stimulate the pituitary and hypothalamus to increase their own gonadotropin secretion. We describe both mechanisms, along with their uses and limitations, in more detail in separate articles — on hCG in TRT and on TRT's effect on fertility.

Beyond symptomatic discomfort, suddenly stopping therapy without a plan and without medical supervision carries concrete risks that are easy to overlook when focusing solely on how you feel. A sharp drop in testosterone below physiological values is associated with worsened mood, and in some men — especially those with a prior history of depression or mood disorders — it can worsen depressive symptoms to a degree requiring intervention rather than just waiting it out. There's also a rapid loss of some of the metabolic and cardiovascular benefits gained during therapy, worsened bone mineral density with a very long period off treatment, and, in men with a urological component (as in the study cited above), a recurrence of urinary problems.

Yes, TRT can be stopped — but "can" doesn't mean "painlessly" or "without risk" if done without a plan. Testosterone doesn't disappear immediately after the last dose, but in the weeks or months that follow it almost always falls below pre-treatment values before your own axis manages to resume work — and how long that takes, and whether it comes back fully at all, depends on age, the length and dose of prior therapy, and whether the original cause of the deficiency was actually fixed. If you're considering stopping, treat it as a medical decision requiring a plan, monitoring, and — in some cases — pharmacological support to speed up the return of your own production, not as something you can simply stop doing overnight.